Drug dependence and prescribing ketamine for treatment-resistant depression in Australia and New Zealand

被引：0
|
作者：
Carroll, Alistair [1 ,2 ,14 ]
Bayes, Adam [1 ,2 ]
Montebello, Mark [3 ,4 ,5 ]
Brett, Jonathan [6 ,7 ,8 ,9 ]
Arunogiri, Shalini [10 ,11 ]
Saunders, John B. [12 ]
Loo, Colleen K. [1 ,2 ,13 ]
机构：
[1] Black Dog Inst, Neuromodulat & Intervent Psychiat, Sydney, NSW, Australia
[2] Univ New South Wales, Sch Clin Med Psychiat & Mental Hlth, Sydney, NSW, Australia
[3] Northern Sydney Local Hlth Dist, Drug & Alcohol Serv, St Leonards, NSW, Australia
[4] Univ Sydney, Specialty Addict Med, Camperdown, NSW, Australia
[5] Univ New South Wales, Natl Drug & Alcohol Res Ctr, Sydney, NSW, Australia
[6] St Vincents Hosp, Clin Pharmacol & Toxicol & Addict Med, Sydney, NSW, Australia
[7] Childrens Hosp Westmead, NSW Poisons Informat Ctr, Westmead, NSW, Australia
[8] Univ New South Wales, St Vincents Clin Sch, Sydney, NSW, Australia
[9] Univ New South Wales, Sch Populat Hlth, Med & Hlth Intelligence, Sydney, NSW, Australia
[10] Eastern Hlth, Turning Point, Statewide Addict & Mental Hlth Ctr, Melbourne, Vic, Australia
[11] Monash Univ, Monash Addict Res Ctr, Melbourne, Vic, Australia
[12] Univ Queensland, Natl Ctr Youth Subst Use Res, Brisbane, Qld, Australia
[13] George Inst Global Hlth, Cardiovasc Program, Sydney, NSW, Australia
[14] Black Dog Inst, Hosp Rd, Sydney, NSW 2031, Australia
来源：
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY | 2024年 / 58卷 / 10期
基金：
英国医学研究理事会; 澳大利亚国家健康与医学研究理事会;
关键词：
Ketamine; drug dependence; depression; regulations; MENTAL-HEALTH; SELF-MEDICATION; OPIOID MISUSE; RISK-FACTORS; CHRONIC PAIN; ABUSE; ANTIDEPRESSANT; COMORBIDITY; DISORDERS; PREVALENCE;
D O I：
10.1177/00048674241242315
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
Ketamine is a restricted and regulated medication in Australia and New Zealand, which has implications when considering treatment for patients with treatment-resistant depression and a history of illicit drug use, abuse or dependence. Regulations governing prescription of ketamine for treatment-resistant depression vary between jurisdictions in Australia and New Zealand, though most restrict use in those with drug dependence. There is substantial variation in definitions of drug dependence used in each jurisdiction, and between the legal and clinical definitions, with the latter specified in the current International Classification of Diseases, Eleventh Revision and Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. This paper reviews the literature assessing the risk of ketamine misuse and dependence in patients with a history of illicit drug use, abuse or dependence and presents recommendations for psychiatrists who prescribe ketamine in such patients with treatment-resistant depression.
引用
收藏
页码：831 / 838
页数：8
相关论文
共 50 条
  • [1] KETAMINE FOR TREATMENT-RESISTANT DEPRESSION: A NEW ADVOCATE
    Perez-Esparza, Rodrigo
    REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 2018, 70 (02): : 65 - 67
  • [2] Intranasal Ketamine in Treatment-resistant Depression
    Lapidus, Kyle A.
    Levitch, Cara F.
    Soleimani, Laili
    Perez, Andrew M.
    Brallier, Jess W.
    Parides, Michael K.
    Iosifescu, Dan V.
    Charney, Dennis S.
    Murrough, James W.
    NEUROPSYCHOPHARMACOLOGY, 2013, 38 : S361 - S361
  • [3] Oral ketamine for treatment-resistant depression
    Kang, Seema
    LANCET PSYCHIATRY, 2018, 5 (11): : 877 - 877
  • [4] Esketamine/ketamine for treatment-resistant depression
    Lacerda, Acioly L. T.
    BRAZILIAN JOURNAL OF PSYCHIATRY, 2020, 42 (06) : 579 - 580
  • [5] KETAMINE FOR ADOLESCENT TREATMENT-RESISTANT DEPRESSION
    Cullen, Kathryn R.
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2017, 56 (10): : S345 - S345
  • [6] SUBLINGUAL KETAMINE FOR TREATMENT-RESISTANT DEPRESSION
    Hyde, S.
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2017, 51 : 154 - 154
  • [7] Ketamine Minus the Trip: New Hope for Treatment-Resistant Depression
    Abbasi, Jennifer
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 318 (20): : 1964 - 1966
  • [8] A systematic review of ketamine for treatment-resistant depression
    Patel, Reshmee
    Loh, Feng-Hua
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 132 - 132
  • [9] The use of subcutaneous ketamine for treatment-resistant depression
    Vargas Alves Nunes, A.
    Carrara, E.
    Odebrecht Vargas Nunes, S.
    Fernandes Jorge, I.
    Alves, E.
    Haddad, M.
    EUROPEAN PSYCHIATRY, 2019, 56 : S95 - S95
  • [10] Feasibility of continuation ketamine for treatment-resistant depression
    aan het Rot, Marije
    Mathew, Sanjay J.
    Collins, Katherine A.
    Perez, Andrew M.
    Murrough, James W.
    Reich, David L.
    Charney, Dennis S.
    BIOLOGICAL PSYCHIATRY, 2008, 63 (07) : 220S - 220S
12345